Fletcher A. White, PhD
Vergil K. Stoelting Professor of Anesthesia
Professor of Pharmacology & Toxicology
Professor of Ophthalmology
Adjunct Professor of Anatomy, Cell Biology & Physiology
Research Scientist, Roudebusch Veterans Administration Medical Center
- Phone
- (317) 274-5164
- Address
-
NB 514D, Neuroscience Research Bldg.
IN
Indianapolis, IN - PubMed:
- CV:
- Download CV
Bio
Fletcher A. White, PhD, is a medically-trained neuroscientist involved in both pre-clinical and clinical research studies for nearly 30 years. His experience in medical/graduate education and university leadership positions at two nationally recognized medical schools—Loyola University, Chicago, and Indiana University School of Medicine—provides Dr. White with a multitude of resources for conducting basic and translational research. Dr. White received a Bachelor of Art (Psychology, 1985) from Baldwin-Wallace College; a Master of Science (Pathology, 1990) and a doctorate (Anatomy and Neurobiology, 1994) from the Medical College of Ohio. His graduate work was followed by postdoctoral training at Washington University in St. Louis (Neurology, 1994-1998) with Dr. William Snider and Massachusetts General Hospital/Harvard Medical School (Anesthesia and Critical Care, 1998-1999) with Dr. Clifford Woolf. He was appointed as an associate research scientist at Yale University School of Medicine in both the Departments of Neurology and Anesthesiology (1999-2002). He joined the faculty of Loyola University Stritch School of Medicine as an assistant professor (Cell Biology, Neurobiology and Anatomy, 2002-2009) where he rose to associate professor and director of research for the Department of Anesthesiology. Dr. White joined Indiana University School of Medicine in October 2009 and became the Vergil K. Stoelting Professor of Anesthesia. Dr. White is an expert in the field of chronic pain mechanisms. His research group studies the sequence and nature of the neuroinflammatory events that govern neuron and non-neuronal communication in the nervous system following injury in both pre-clinical models and clinical subjects. Many of these events may be critical for the discovery of new mechanisms and targets for chronic pain treatment. His hobbies include hiking, travel, reading, ACDs and social issues.
Key Publications
Towards precision medicine for pain: diagnostic biomarkers and repurposed drugs.
Niculescu AB, Le-Niculescu H, Levey DF, Roseberry K, Soe KC, Rogers J, Khan F, Jones T, Judd S, McCormick MA, Wessel AR, Williams A, Kurian SM, White FA. Mol Psychiatry. 2019 Apr;24(4):501-522. doi: 10.1038/s41380-018-0345-5. Epub 2019 Feb 12. PMID:30755720
Small-molecule CaVα1⋅CaVβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking.
Chen X, Liu D, Zhou D, Si Y, Xu D, Stamatkin CW, Ghozayel MK, Ripsch MS, Obukhov AG, White FA, Meroueh SO. Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10566-E10575. doi: 10.1073/pnas.1813157115. Epub 2018 Oct 24. PMID:30355767
Year | Degree | Institution |
---|---|---|
1994 | PhD | Medical College of Ohio |
1989 | MS | Medical College of Ohio |
1985 | BA | Baldwin Wallace College |
A large proportion of my research has been directed at the influence of tissue-derived factors on the nervous system during development and following disease/trauma. The body of this work includes the role of neurotrophins during neurodevelopment/apoptosis(NGF/TrkA & NT3/TrkC), axon guidance molecules during development (semaphorins), the role of chemokines/receptors in adult rodent injury models (CCL2/CCR2 and CXCL12/CXCR4), the influence of toll-like receptor-4 (TLR4) in the peripheral nervous system, study of drug-induced changes in voltage-gated sodium channels such as NaV1.7, and the influence of damage-associated molecular patterns (DAMPs) and their cognate receptors in both neuropathic pain syndromes and following traumatic brain injury. As PI or co-investigator on several university-, state-, NIH- and DOD-funded grants, I have established productive intramural and extramural research collaborations allowing me to utilize a variety of injury models including a newly developed closed head injury in mice. We have numerous molecular biological techniques, transgenic mice (CRISPR knockouts, Cre-lox tissue-specific knockout, optogenetic and GCamp3 lines), neuroanatomical tract tracing, electrophysiology (current and voltage clamp), telemetry, immunocytochemistry, stimulus dependent and independent measures of rodent behavior and access to both clinical databases and specimens.
Charouf D; Miller D; Haddad L; White FA; Boustany RM; Obeid M; International journal of molecular sciences 2024 Sep 6
Miller J; Jacobs S; Koppes W; Minella F; Porta F; White FA; Lovelace JA; medRxiv : the preprint server for health sciences 2024 Sep 19
El Jammal R; Tfaily A; Cochran AG; Nguyen T; Miller D; El Ayoubi N; Soluoku T; White FA; Obeid M; Epilepsy & behavior : E&B 2024 Oct 29
Lahiri DK; Maloney B; Wang R; White FA; Sambamurti K; Greig NH; Counts SE; Ageing research reviews 2024 May 11
Fogel EL; Easler JJ; Yuan Y; Yadav D; Conwell DL; Vege SS; Han SY; Park W; Patrick V; White FA; JMIR research protocols 2024 Mar 7
Smith AB; Jung M; O'Donnell D; White FA; Pressler SJ; The Journal of cardiovascular nursing 2024 Jul 10
Nazzal MK; Morris AJ; Parker RS; White FA; Natoli RM; Kacena MA; Fehrenbacher JC; Current osteoporosis reports 2024 Jan 31
Parker RS; Nazzal MK; Morris AJ; Fehrenbacher JC; White FA; Kacena MA; Natoli RM; Current osteoporosis reports 2024 Jan 18
Morris AJ; Parker RS; Nazzal MK; Natoli RM; Fehrenbacher JC; Kacena MA; White FA; Current osteoporosis reports 2024 Jan 18
Smith AB; Jung M; Pressler SJ; Western journal of nursing research 2024 Jan 17
Nazzal MK; Morris AJ; Parker RS; White FA; Natoli RM; Fehrenbacher JC; Kacena MA; Current osteoporosis reports 2024 Jan 13
Solanki K; Bezsonov E; Orekhov A; Parihar SP; Vaja S; White FA; Obukhov AG; Baig MS; Vascular pharmacology 2024 Feb 5
Meng L; Rasmussen M; Meng DM; White FA; Wu LJ; Anesthesia and analgesia 2024 Feb 12
Smith JA; Nguyen T; Davis BC; Lahiri DK; Hato T; Obukhov AG; White FA; Frontiers in neuroscience 2023 Sep 12
Zhang W; Wang M; Lv W; White FA; Chen X; Obukhov AG; Cells 2023 May 3
Smith JA; Nguyen T; Karnik S; Davis BC; Al-Juboori MH; Kacena MA; Obukhov AG; White FA; Journal of neuroimmunology 2023 May 16
Ludwig N; Demaree IS; Yamada C; Nusbaum A; Nichols FC; White FA; Movila A; Obukhov AG; International journal of molecular sciences 2023 Jan 3
Naugle KM; Nguyen T; Smith JA; Saxe J; White FA; Journal of neurotrauma 2023 Feb 24
Nguyen T; Nguyen N; Cochran AG; Smith JA; Al-Juboori M; Brumett A; Saxena S; Talley S; Campbell EM; Obukhov AG; White FA; Journal of neuroinflammation 2023 Aug 27
Radulescu A; White FA; Chenu C; Journal of pain research 2022 Sep 13
Choi GJ; Kang H; Lee OH; Ahn EJ; White FA; Cho YJ; Baek CW; Jung YH; Kwon JW; BMC complementary medicine and therapies 2022 Jan 11
Ping X; Chai Z; Wang W; Ma C; White FA; Jin X; Epilepsia 2021 Sep 18
Naugle KM; Corrona S; Smith JA; Nguyen T; Saxe J; White FA; Pain reports 2021 Oct 29
Kirtley PR; Sooch GS; White FA; Obukhov AG; Cells 2021 Feb 25
Min HJ; Kim KS; Choi GJ; Kang H; White FA; International journal of medical sciences 2021 Feb 18
Munjuluri S; Wilkerson DA; Sooch G; Chen X; White FA; Obukhov AG; Cells 2021 Dec 22
Kacena MA; White FA; EBioMedicine 2020 Sep 22
Okui T; Hiasa M; Ryumon S; Ono K; Kunisada Y; Ibaragi S; Sasaki A; Roodman GD; White FA; Yoneda T; Journal of bone oncology 2020 Oct 28
Naugle KM; Carey C; Evans E; Saxe J; Overman R; White FA; The journal of headache and pain 2020 Dec 3
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI; Journal of cellular biochemistry 2019 May 20
The unique environment of the Indiana University School of Medicine and Roudebush Veterans Medical Center allows me to also conduct a number of clinical observational and interventional investigations. These IRB-approved studies include biomarkers associated with 1) polytrauma alone and polytrauma with traumatic brain injury, 2) development of chronic pain following mild traumatic brain injury, and 3) a phase II drug trial using a FDA-approved anti-epileptic drug as an adjuvant to opioids for cancer pain.